|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Impel NeuroPharma (NASDAQ: IMPL) through any online brokerage.
There are no as such competitors for Impel NeuroPharma.
The latest price target for Impel NeuroPharma (NASDAQ: IMPL) was reported by Guggenheim on May 18, 2021. The analyst firm set a price target for 32.00 expecting IMPL to rise to within 12 months (a possible 151.37% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Impel NeuroPharma (NASDAQ: IMPL) is $12.73 last updated Today at 8:00:02 PM.
There are no upcoming dividends for Impel NeuroPharma.
There is no upcoming split for Impel NeuroPharma.
Impel NeuroPharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.